Y-Intercept (HK)
ALNY icon

Y-Intercept (HK)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Y-Intercept (HK)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-6,561
Closed -$1.98M – 1550
2026
Q2 		$1.98M Sell
6,561
-4,800
-42% -$1.45M 0.04% 714
2026
Q1 		$3.76M Buy
+11,361
New +$3.87M 0.07% 437
2025
Q4 		– Sell
-2,614
Closed -$1.19M – 1506
2025
Q3 		$1.19M Buy
+2,614
New +$1.06M 0.03% 892
2025
Q2 		– Sell
-3,720
Closed -$1M – 1610
2025
Q1 		$1M Sell
3,720
-796
-18% -$205K 0.07% 404
2024
Q4 		$1.06M Buy
+4,516
New +$1.19M 0.07% 403
2024
Q3 		– Sell
-46,388
Closed -$11.3M – 1269
2024
Q2 		$11.3M Buy
46,388
+43,545
+1,532% +$6.87M 0.62% 11
2024
Q1 		$425K Buy
2,843
+988
+53% +$165K 0.03% 796
2023
Q4 		$355K Buy
+1,855
New +$316K 0.03% 757
2022
Q4 		– Sell
-5,935
Closed -$1.19M – 972
2022
Q3 		$1.19M Buy
+5,935
New +$1.13M 0.12% 267
2022
Q1 		– Sell
-3,134
Closed -$531K – 706
2021
Q4 		$531K Buy
+3,134
New +$582K 0.13% 235
2021
Q3 		– Sell
-7,592
Closed -$1.29M – 629
2021
Q2 		$1.29M Buy
7,592
+3,832
+102% +$561K 0.33% 59
2021
Q1 		$508K Buy
+3,760
New +$566K 0.14% 254

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Y-Intercept (HK)'s ALNY Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2026, closing a stake of 6,561 shares — an estimated $1.98M sold.

Y-Intercept (HK) first reported a position in ALNY in Q1 2021 and held it in 12 quarters. The position peaked at $11.3M in Q2 2024. 591 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Alnylam Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 6,561 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $1.98M.
  • Y-Intercept (HK) first reported a position in Alnylam Pharmaceuticals in Q1 2021 and held it in 12 quarters.
  • Y-Intercept (HK)'s Alnylam Pharmaceuticals position peaked at $11.3M in Q2 2024.
  • 591 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.